Rather, our results suggest that in patients with NAFLD, certain TLRs, and herein, probably especially TLR1 are induced in PBMCs and that this might also reflect elevated levels of certain bacterial toxins in peripheral blood. The gene discussed is TLR1; the disease is metabolic dysfunction-associated steatotic liver disease.